Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference

Rhea-AI Summary

Whitehawk Therapeutics (NASDAQ: WHWK), an oncology therapeutics company focused on ADC cancer treatments, will participate in the Jefferies 2025 Global Healthcare Conference in New York City from June 3-5, 2025. CEO Dave Lennon will deliver a company overview presentation on June 4, 2025, from 2:00-2:30 PM ET. The presentation will be available via webcast on the company's IR website and accessible for replay for approximately 30 days after the event.

News Market Reaction – WHWK

-3.33%

-3.33% Session move

In the trading session that priced this news, WHWK declined 3.33%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MORRISTOWN, N.J., May 28, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today its presentation at the Jefferies 2025 Global Healthcare Conference, taking place June 3-5, 2025, in New York City, NY. Dave Lennon, PhD, President and CEO, will present a company overview on Wednesday, June 4, 2025, from 2:00-2:30 PM ET.

A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR website and will be available for replay for approximately 30 days following the event.

About Whitehawk Therapeutics

Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. More information on the Company is available at www.whitehawktx.com and connect with us on LinkedIn.

Contact:
IR@whitehawktx.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-present-at-the-jefferies-2025-global-healthcare-conference-302466333.html

SOURCE Whitehawk Therapeutics, Inc.

FAQ

When is Whitehawk Therapeutics (WHWK) presenting at the Jefferies Healthcare Conference 2025?

Whitehawk Therapeutics will present on Wednesday, June 4, 2025, from 2:00-2:30 PM ET at the Jefferies Global Healthcare Conference in New York City.

Who will be presenting for Whitehawk Therapeutics (WHWK) at the Jefferies Conference?

Dave Lennon, PhD, President and CEO of Whitehawk Therapeutics, will present the company overview.

How can I watch Whitehawk Therapeutics' (WHWK) presentation at the Jefferies Conference?

The presentation can be accessed via live webcast on Whitehawk Therapeutics' IR website and will be available for replay for approximately 30 days after the event.

What is Whitehawk Therapeutics' (WHWK) main business focus?

Whitehawk Therapeutics is an oncology therapeutics company that applies advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments.